FINNENCE ▪ THE WIRE FILE
THE WIRE · № 71557
Company▼ Bearish
Phase 3 results posted: Study of Ataluren in Previously Treated Participants With Nonsense Mutation Dystrophinopathy (nmDBMD) — PTC Therapeutics
KINDCompany
DIRECTION▼ Bearish
SOURCES1
ENTITIES1
STORY SIZESTANDALONE
FIRST SEEN2026-10-08 12:00 UTC
LAST UPDATE2026-10-08 12:00 UTC
STATEactive
01 THE MACHINE READ
WHY IT MATTERS.
A terminated Phase 3 in Duchenne removes a potential revenue path for PTC Therapeutics.
Terminated DMD trial removes a pipeline catalyst
CATALYST TO WATCH
Any replacement program disclosure
MAIN RISK
Further pipeline attrition at PTC
FULL DISPATCH
Sponsor: PTC Therapeutics; Status: Terminated; Conditions: Duchenne Muscular Dystrophy; Interventions: Ataluren; Enrollment: 265 (actual); First posted: 2010-11-24; Results posted: 2026-10-08; NCT: NCT01247207
02 THE STORY SO FAR
THE RECORD, IN ORDER.
STANDALONE ITEM — NOT YET FOLDED INTO A DEVELOPING STORY.
03 WHO'S INVOLVED
ENTITIES ON FILE.
AFFECTEDHealthcare
04 RECEIPTS
THE SOURCE RECORD.
1 SOURCES CONFIRMED05 PROPAGATION
WHAT THIS TOUCHES.
→CORRELATIONshares Healthcare
Phase 3 results posted: A Study to Compare How Well Gadoquatrane Works and Its Safety With an Already Available Contrast Agent for MRI in People With Known or Suspected Brain or Spinal Cord-related Problems — Bayer2026-10-08 12:00 UTC
Phase 3 results posted: A Study to Compare How Well Gadoquatrane Works and Its Safety With an Already Available Contrast Agent for MRI in People With Known or Suspected Brain or Spinal Cord-related Problems — Bayer2026-10-08 12:00 UTC
→CORRELATIONshares Healthcare
Phase 3 results posted: Safety Study of Viaskin Peanut to Treat Peanut Allergy — DBV Technologies2026-10-08 12:00 UTC
Phase 3 results posted: Safety Study of Viaskin Peanut to Treat Peanut Allergy — DBV Technologies2026-10-08 12:00 UTC
→CORRELATIONshares Healthcare
Telix Pharmaceuticals: Merger Bodes Well For Long-Term Plan (NASDAQ:TLX)2026-10-08 15:31 UTC
Telix Pharmaceuticals: Merger Bodes Well For Long-Term Plan (NASDAQ:TLX)2026-10-08 15:31 UTC
→CORRELATIONshares Healthcare
Apodex Opens Free AI Computing Services to Accelerate Drug Research2026-10-08 17:25 UTC
Apodex Opens Free AI Computing Services to Accelerate Drug Research2026-10-08 17:25 UTC
→CORRELATIONshares Healthcare
WallachBeth Capital Announces bioAffinity Technologies Approximately $4 Million Registered Direct Financing of Common Stock and Concurrent Private Placement Priced At-The-Market Under Nasdaq Rules2026-10-08 17:30 UTC
WallachBeth Capital Announces bioAffinity Technologies Approximately $4 Million Registered Direct Financing of Common Stock and Concurrent Private Placement Priced At-The-Market Under Nasdaq Rules2026-10-08 17:30 UTC
→CORRELATIONshares Healthcare
Phenomenex Introduces Strata-Mag RP to Enable Automated LC-MS/MS Sample Preparation at Scale2026-10-08 17:45 UTC
Phenomenex Introduces Strata-Mag RP to Enable Automated LC-MS/MS Sample Preparation at Scale2026-10-08 17:45 UTC
KEEP READING THE MACHINE
Summaries are generated and may contain errors — every claim links its sources.